Raphael Dolin, MD serves as Maxwell Finland Professor of Medicine, Microbiology and Molecular Genetics and Dean for Academic and Clinical Programs at Harvard Medical School. He has authored more than 200 articles, books, chapters, and reviews, and his major research focus is in the development and clinical study of candidate HIV vaccines. Dr. Dolin is one of the world’s leading experts on retroviral infections and is the lead editor for AIDS Therapy, 3rd Edition and an editor of the 7th edition of Mandell, Douglas, and Bennett’s Principles & Practice of Infectious Diseases.
Dr. Dolin launched his academic career as a professor of medicine at University of Vermont College of Medicine, where he also served as Head of the Infectious Disease Unit, after serving in various positions at the National Institute of Allergy and Infectious Diseases (NIAID). He also held leadership positions at the University of Rochester and Strong Memorial Hospital. Dr. Dolin is a fellow of the American College of Physicians, the Infectious Diseases Society of America, and the Molecular Medicine Society, and maintains memberships in professional organizations including the American Association of Physicians, the American Society for Clinical Investigation, American Federation for Medical Research, and the American Society for Microbiology. Dr. Dolin has also served as the Chair of the Board of Scientific Counselors for the NIH Vaccine Research Center.